The Quaestio Announces Synthetic Biology Playbook 2025

February 20, 2025 09:22 AM PST | By EIN Presswire

Google News:

The Quaestio Announces Synthetic Biology Playbook 2025 — Image source: EIN Presswire

Recent News

XPeng Inc (NYSE:XPEV) Shareholders React to Market Cap Slide NYSE Comp...

Cardinal Health (NYSE:CAH) Sees Strength in Specialty Pharma Segment S...

Sysco (NYSE:SYY) Stock Strengthens With Michelin Partnership S&P 500

Johnson & Johnson Stock Declines Amid Talcum Dow Jones Industrial Aver...

BERKELEY, CA, UNITED STATES, February 20, 2025 /EINPresswire.com/ -- The Quaestio proudly announces the launch of its latest “Synthetic Biology Playbook” report, offering an in-depth analysis of the fast-evolving synthetic biology landscape. Modelled after the success of The Quaestio’s KnowledgeHub platform — launched in September — this comprehensive report delivers useful insights for decision-makers, innovators, and investors seeking to adopt and accelerate synthetic biology.

An All-Encompassing View of Synthetic Biology

The new report serves as a definitive guide for stakeholders across the ecosystem. It goes beyond market size and forecasts, diving into players, technologies, funding patterns, patents, papers, and regulatory frameworks shaping the field.

Key Highlights

1. Market Deep-Dive
o Market Overview 2024–2029: Projections on global synthetic biology growth, segmented by geography, technology, application, and end-use.

o Growth & Opportunities: An in-depth look at high-potential sectors, including gene therapy, advanced materials, and novel chassis organisms.

2. SynBio Ecosystem
o 2024 Player Map: A detailed breakdown of developers, adopters, and key ecosystem enablers.

o Emerging Startups: Profiles of new entrants spun out from top-tier universities or stealth mode.

o Application Landscape: Industry-specific segmentation highlighting medical, chemical, and materials sub-segments.

3. Geographical Landscape
o Regional Insights: Comprehensive coverage of synthetic biology hotspots, including the United States, China, Denmark, India, Japan, and more.

o Regulatory & Policy Updates: Latest legal frameworks and policy implementations impacting market entry and growth.

4. Technology Frontiers
o Cost & Safety: Addressing challenges such as DNA hacking, mirror bacteria, and decreasing sequencing costs.

o Innovations: Breakthroughs in AI-driven gene editing, cell-free systems, and chassis design.

5. Market Dynamics
o News & Industry Activities Overview: Month-over-month analysis of major industry events, strategic collaborations, acquisitions, and product launches that are reshaping the market landscape.

o Collaborations & Consolidations: Detailed insights into recent mergers, strategic partnerships, and market exits, providing a snapshot of the competitive dynamics.

6. Funding Trends
o Investment Landscape: Detailed breakdown of venture investments, seed funding, series A, and government grants, including regional and monthly funding insights.

o Top Investors & Venture Arms: Analysis of key funding sources, highlighting major investors driving innovation in synthetic biology.

7. Patents & Papers
o Patent Insights: Comprehensive data on patent filings, classifications, and key research focus areas, offering a clear view of the competitive innovation landscape.

o Scientific Publications: Analysis of industry research trends, top journals, and influential papers that are shaping the field.

8. Predictions
o Expert forecasts on the trajectory of synthetic biology, highlighting emerging technologies and market opportunities through 2025.

Beyond the Report: KnowledgeHub Synergy

The KnowledgeHub platform, launched in September, offers real-time intelligence and personalized analyst support. This “Synthetic Biology Playbook” report complements the platform by providing an annual, consolidated view of the field’s current state and future possibilities.

Access the Report: To request a copy or learn more about The Quaestio’s KnowledgeHub, please visit: KnowledgeHub for Synthetic Biology

About The Quaestio

The Quaestio is a research and business intelligence firm that helps organizations navigate complex challenges in emerging technology domains. Through data-driven insights, technology scouting, and strategic consulting, The Quaestio enables global enterprises, startups, and policymakers to stay ahead of market disruptions

Deepali Barai
Quaestio LLP
[email protected]
Visit us on social media:
LinkedIn
X
Facebook
Instagram

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video (Content) is a service of Kalkine Media LLC., having Delaware File No. 4697309 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.